Abstract | OBJECTIVES: MATERIALS AND METHODS: We analyzed 78 specimens representing bladder urothelial carcinoma, as well as 4 bladder urothelial carcinoma cell lines, by immunostaining with a battery of anticarbohydrate antibodies. We also undertook an E-selectin·IgM chimera binding assay to assess E-selectin binding to 6-sulfo sLeX expressed on bladder urothelial carcinoma cells and performed reverse transcription polymerase chain reaction and complementary DNA transfection to determine which N-acetylglucosamine-6-O-sulfotransferases function in 6-sulfo sLeX biosynthesis in those cells. Finally, we performed double-immunofluorescence staining for MECA-79 and either CD3 or CD8 to evaluate potential association between high endothelial venule (HEV)-like vessels and tumor-infiltrating T lymphocytes. RESULTS: 6-Sulfo sLeX glycans were expressed in ~20% of bladder urothelial carcinoma cases, particularly in plasmacytoid and micropapillary variants. Positive cells were also bound by E-selectin·IgM chimeras in a calcium-dependent manner. Transcripts encoding N-acetylglucosamine-6-O-sulfotransferase-2 were detected preferentially in HT-1197 bladder urothelial carcinoma cells expressing 6-sulfo sLeX, and transfection of the enzyme complementary DNA into HT-1376 cells, which do not express 6-sulfo sLeX glycans, resulted in cell surface expression of 6-sulfo sLeX. Furthermore, 6-sulfo sLeX glycans were expressed in HEV-like vessels induced in and around lymphocyte aggregates formed near carcinoma cell nests. These HEV-like vessel-associated tumor-infiltrating lymphocytes were composed primarily of CD3(+) T cells, with a fraction of CD8(+) cytotoxic T cells. CONCLUSIONS: Our findings indicate that 6-sulfo sLeX glycans likely play 2 roles in bladder urothelial carcinoma progression: one in lymphocyte recruitment to enhance antitumor immune responses, and the other in E-selectin-mediated tumor cell adhesion to vascular endothelial cells, which is potentially associated with metastasis.
|
Authors | Minekatsu Taga, Hitomi Hoshino, Shulin Low, Yoshiaki Imamura, Hideaki Ito, Osamu Yokoyama, Motohiro Kobayashi |
Journal | Urologic oncology
(Urol Oncol)
Vol. 33
Issue 11
Pg. 496.e1-9
(Nov 2015)
ISSN: 1873-2496 [Electronic] United States |
PMID | 26137907
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- 6'-sulfated sialyl Lewis x
- E-Selectin
- Lewis X Antigen
- Oligosaccharides
- RNA, Messenger
- SELE protein, human
- Sialyl Lewis X Antigen
- Sulfotransferases
- carbohydrate sulfotransferases
|
Topics |
- Adenocarcinoma
(genetics, metabolism, secondary)
- Aged
- Aged, 80 and over
- E-Selectin
(genetics, metabolism)
- Female
- Fluorescent Antibody Technique
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Lewis X Antigen
(analogs & derivatives)
- Male
- Middle Aged
- Neoplasm Staging
- Oligosaccharides
(genetics, metabolism)
- Prognosis
- RNA, Messenger
(genetics)
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Sialyl Lewis X Antigen
(analogs & derivatives)
- Sulfotransferases
(genetics, metabolism)
- Urinary Bladder Neoplasms
(genetics, metabolism, pathology)
|